F18FDG PET/TC y TC abdominal trifásico
un protocolo de exploración combinada para la evaluación de metástasis hepáticas en el carcinoma colorrectal
Palabras clave:
AbdomenResumen
Proponer un protocolo de diagnóstico por imagen que permita integrar en una sola exploración la 18F-FDG PET/TC y la TC en protocolo trifásico abdominal (TCEaCT) en la evaluación posterapéutica de metástasis hepáticas inicialmente no resecables.
Descargas
Los datos de descargas todavía no están disponibles.
Citas
1. Kinkel K, Lu Y, Both M, Warren RS, Thoeni RF. Detection of hepatic metastases from cancer of the gastrointestinal tract by using non invasive imaging methods (US, CT, MR Imaging, PET): a meta-analysis. Radiology 2002; 224:748-756.
2. Bipat S, van Leeuwen MS, Comans EFI, et al. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis-metaanalysis. Radiology 2005; 237:123-131.
3. Selzner M, Hany TF,Wildbrett P, McCormack L, Kadry Z, Clavien PA. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 2004; 240:1027-1036.
4. Mainenti PP, Mancini M, Mainolfi C, Camera L, Maurea S, Manchia A. Detection of colo-rectal liver metastases: prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1.5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents. Abdom Imaging. 2009 Jun 27. [Epub ahead of print].
5. Rappeport ED, Loft A, Berthelsen AK, von der Recke P, Larsen PN, Mogensen AM, et al. Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation Acta Radiol. 2007 May;48(4):369-78.
6. Akhurst T, Kates TJ, Mazumdar M, et al. Recent chemotherapy reduces the sensitivity of FDG PET in the detection of colorectal metastases. J Clin Oncol. 2005; 23;: 8713-6.
7. Selzner M, Hany TF, Wildbrett P, et al. Does the novel PET-CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg. 2004; 240: 1027-36.
8. D'souza MM, Sharma R, Mondal A, Jaimini A, Tripathi M, Saw SK, et al. Prospective evaluation of CECT and 18F-FDG-PET/CT in detection of hepatic metastases. Nucl Med Commun. 2009 Feb;30(2):117-25.
9. Badiee S, Franc BL, Webb EM, Chu B, Hawkins RA, Coakley F, et al. Role of IV iodinated contrast material in 18F-FDG PET/CT of liver metastases. AJR Am J Roentgenol. 2008 Nov;191(5):1436-9.
2. Bipat S, van Leeuwen MS, Comans EFI, et al. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis-metaanalysis. Radiology 2005; 237:123-131.
3. Selzner M, Hany TF,Wildbrett P, McCormack L, Kadry Z, Clavien PA. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 2004; 240:1027-1036.
4. Mainenti PP, Mancini M, Mainolfi C, Camera L, Maurea S, Manchia A. Detection of colo-rectal liver metastases: prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1.5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents. Abdom Imaging. 2009 Jun 27. [Epub ahead of print].
5. Rappeport ED, Loft A, Berthelsen AK, von der Recke P, Larsen PN, Mogensen AM, et al. Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation Acta Radiol. 2007 May;48(4):369-78.
6. Akhurst T, Kates TJ, Mazumdar M, et al. Recent chemotherapy reduces the sensitivity of FDG PET in the detection of colorectal metastases. J Clin Oncol. 2005; 23;: 8713-6.
7. Selzner M, Hany TF, Wildbrett P, et al. Does the novel PET-CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg. 2004; 240: 1027-36.
8. D'souza MM, Sharma R, Mondal A, Jaimini A, Tripathi M, Saw SK, et al. Prospective evaluation of CECT and 18F-FDG-PET/CT in detection of hepatic metastases. Nucl Med Commun. 2009 Feb;30(2):117-25.
9. Badiee S, Franc BL, Webb EM, Chu B, Hawkins RA, Coakley F, et al. Role of IV iodinated contrast material in 18F-FDG PET/CT of liver metastases. AJR Am J Roentgenol. 2008 Nov;191(5):1436-9.
Descargas
Publicado
2018-11-22
Cómo citar
Domínguez Ferreras, E., & García Vicente, A. M. (2018). F18FDG PET/TC y TC abdominal trifásico: un protocolo de exploración combinada para la evaluación de metástasis hepáticas en el carcinoma colorrectal. Seram. Recuperado a partir de https://piper.espacio-seram.com/index.php/seram/article/view/3158
Número
Sección
Abdominal
